Astrazeneca Pharma India Limited (“Astrazeneca” or the “Company”) covers the manufacturing, sales and marketing activities of the company in India. The Company is committed to deliver life-changing medicines to patients through innovative science and global excellence in development and commercialization. The Company has an innovative portfolio in crucial areas of healthcare including cardiovascular, renal &…
When selecting stocks, it is difficult to review the massive amount of data available from various sources for assessing equity fundamentals. Developing a good stock selection criteria for evaluating stocks can make this tedious task much less stressful. That being said, a bigger problem these days is to select a stock selection criteria. Just type…
Over the past few years, The Reserve Bank of India (RBI) has consistently lowered interest rates. Consider this, The RBI has lowered its Repo Rate (i.e. the rate at which RBI lends to commercial banks) from a high of 8% in 2015 to its current rate of 4%. Falling interest rates have resulted in a significant reduction in…
Assume a fund growth between 8-9% p.a. (there are many such funds). Effectively such a fund is paying 0.67-0.75% per month. In reality, returns are not linear. I.e. based on interest rate scenario fund will move up say 1% in a given month and move only 0.1% in yet another month but will grow at…
A few days back, I wrote an article on various debt mutual funds and what investors must consider before investing. Some of the questions I received gave me the idea of writing this part 2. I will try to explain basic debt fund terminology here. What is Yield to Maturity (YTM)? Debt mutual funds, being market…
L&T Finance Holding Limited (“L&T Finance” or the “Company”) is promoted by one of India’s leading construction companies- Larsen & Toubro (L&T). The Company offers a comprehensive portfolio of financial products and services through its wholly-owned subsidiaries. L&T Finance’s lending activities are divided into 2 segments – Retail (which accounts for ~53% of AUMs) and…
TATA ELXSI STOCK PRICE: Rs. 778 Tata Elxsi Limited (“Tata Elxsi” or the “Company”) is amongst the world’s leading providers of design and technology services across industries including Automotive, Broadcast, Communications and Healthcare. Tata Elxsi is helping customers through design thinking and application of digital technologies such as IoT (Internet of Things), Cloud, Mobility, Virtual…
A few days back somebody asked me why I do not disclose the portfolio of stocks I am holding. He went on to ask me if I have sold Maruti Suzuki, a stock I had never ever purchased. He showed me an article where I was quoted as saying “ …. It makes a good…
Over the last few weeks, I have been reading many articles on various aspects of debt fund investing. I have also received many queries on where investors should park their money to cushion against stock market uncertainty. To quote some of the more relevant questions: Are debt funds safe? So many companies are defaulting, will…
Over the past few weeks, I have made some major changes to client portfolios. The ongoing credit crisis perhaps has changed my general tone on stocks, and other financial assets. I am not trying to rein in on anyone, nor suggest that a Multicap approach is astute right now, yet some of the things I…
With all this talk about Nifty PE ratio and what is most likely going to be a deteriorating earning season, I decided to have a look at how expensive/ cheap each stock on the Nifty really is. Of course, in absolute numbers, now at 9,266; historically speaking, Nifty is fairly valued at a P/E multiple…
Price: Rs. 253.75 Date: March 30th 2020 Cadila Healthcare Limited (“Cadila” or the “Company”) is a pharmaceutical company that discovers, develops, and manufactures a broad range of healthcare products including human formulations, veterinary formulations and drugs, diagnostics, herbal products, skin care products, Over the Counter (OTC) products and Active Pharmaceutical Ingredients (APIs). The Company has…
SEBI Registered Investment Advisor INA100004608